10.1523/jneurosci.0529-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar] Meng X., Song Q., Liu Z., Liu X., Wang Y., Liu J
Quality Assurance Notice
Experience visible rejuvenation with this GHK-Cu Copper Peptide Smoothing & Firming Face Serum , a high-performance concentrate designed to restore the structural integrity of aging skin
Diabetes Obes Metab 19:16691680 Tonneijck L, Smits MM, Muskiet MHA, Hoekstra T, Kramer MHH, Danser AHJ et al (2016) Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial
This assistance was carried out in accordance with Good Publication Practice (GPP 2022) and the ICMJE requirements
Currently, DPP-IV inhibitors are widely used as monotherapy or combination therapy for the treatment of patients with T2DM